$26.5 Bn Next Generation Sequencing Market to 2025 - Global Analysis and Forecasts by Product, Service, Application & End User - ResearchAndMarkets.com

DUBLIN--()--The "Next Generation Sequencing Market to 2025 - Global Analysis and Forecasts by Product, Service, Application & End User" report has been added to ResearchAndMarkets.com's offering.

The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the forecast period from 2018 to 2025, rising from US$ 5,731.3 Mn in 2017

The growth of next generation sequencing market is attributed to the substantial decline in the prices of sequencing. For example, the cost of sequencing in 2006 was around US $ 10 billion, which eventually dropped down to US$ 5,000 billion in 2012. Various market players such as Roche and Illumina have introduced sequencing techniques which have reduced the cost associated with sequencing.

However, there are risks associated with genetic data which prove to be a major restraint in the market for next generation sequencing. One of the prominent risk associated is targeted marketing of drugs to individuals and family groups. Genetic data is also sold by companies to outside parties.

For instance, 23andMe sold access to its database to around 13 other party pharmaceutical firms. Such risks associated with genetic data is likely to hamper growth of the market over the coming years. Recent developments in technologies has enabled companies to produce sequencing in a single day at the cost of about $15 per sample. It results in effective delivery of target and whole genome data for thousands of samples at a reasonable cost

The market for next generation sequencing has witnessed remarkable growth opportunities in North America. Factors such as increasing focus of market players in the US and Canada, grants & funds by NIH in US and rising prevalence of Cancer in Mexico is likely to boost the growth of NGS market in North America

Key Topics Covered:

1 Introduction

2 Key Takeaways

3 Next Generation Sequencing Market Landscape

4 Next Generation Sequencing Market - Key Industry Dynamics

5 Next Generation Sequencing Market Analysis- Global

6 Next Generation Sequencing Market Revenue and Forecasts To 2025 - Product

7 Next Generation Sequencing Market Revenue and Forecasts To 2025 - Technology

8 Next Generation Sequencing Market Revenue and Forecasts To 2025 - Application

9 Next Generation Sequencing Market Revenue and Forecasts To 2025 - End User

10 North America Next Generation Sequencing Market Revenue and Forecasts To 2025 - Country Analysis

11 Europe Next Generation Sequencing Market Revenue and Forecasts To 2025 - Country Analysis

12 Asia Pacific Next Generation Sequencing Market Revenue and Forecasts To 2025 - Country Analysis

13 Middle East and Africa (Mea) Next Generation Sequencing Market Revenue and Forecasts To 2025 - Country Analysis

14 South and Central America Next Generation Sequencing Market Revenue and Forecasts To 2025 - Country Analysis

15 Industry Landscape

16 Next Generation Sequencing Market, Key Company Profiles

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • Beijing Genomics Institute
  • Perkinelmer, Inc.
  • F. Hoffmann-La Roche AG
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies, Ltd.
  • Macrogen, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/cwb74c/26_5_bn_next?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Molecular Diagnostics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Molecular Diagnostics